Jeff Aronin – The Incubator

Jeff S. Aronin is a talented entrepreneur committed to improving the quality of life for those living with diseases for which there is no known treatment. Through serving as the chairman and CEO of Paragon Biosciences, Mr. Aronin fulfills his mission of providing patient care to improve the patient’s quality of life. Mr. Aronin utilizes his entrepreneurial experience and his 20 years in the field of biopharmaceuticals, to develop biotechnology companies that can accelerate advances in the therapeutic treatment of debilitating diseases like Alzheimer’s and genetic oncology (https://www.jeffaronin.com/).

Mr. Aronin became passionate about developing innovative medicines following a discussion with a physician he was shadowing who shared he would use medicine as an alternative to surgery to help a child suffering from seizures. That encounter sparked Jeff Aronin’s commitment to assist in the development of drugs to help patients. As a result, Jeff S. Aronin has spent 20 years in healthcare, merging his entrepreneurial skill and business acumen with biotechnological companies committed to research and development. Since 2010, he has been at the helm of Paragon Biosciences.

After graduating from DePaul University with an MBA, Aronin founded his first healthcare company in 2000. Jeff S. Aronin found a niche in the healthcare field by focusing on patients with unmet medical needs and committing to developing drugs to address those health challenges. Aronin and Paragon Biosciences succeeded in securing 13 FDA approvals for new drugs, developed by the R&D companies operating under the Paragon Biosciences portfolio of companies. By serving as an incubator that invests in biotechnological companies, Jeff S. Aronin and Paragon Biosciences have emerged as one of the top innovative healthcare companies in the industry and a powerhouse in biotechnology. The winning formula developed by Aronin and his team at Paragon Biosciences is to focus on the patient, identify their need, and conduct the research necessary to develop and commercialize a medicine to treat the patient.

Not one to rest on his laurels, Jeff S. Aronin donates to various philanthropic causes and he serves as a mentor to other entrepreneurs